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The low-molecular-mass rhoptry complex of Plasmodium falciparum consists of three proteins, rhoptry-
associated protein 1 (RAP1), RAP2, and RAP3. The genes encoding RAP1 and RAP2 are known; however, the
RAP3 gene has not been identified. In this study we identify the RAP3 gene from the P. falciparum genome
database and show that this protein is part of the low-molecular-mass rhoptry complex. Disruption of RAP3
demonstrated that it is not essential for merozoite invasion, probably because RAP2 can complement the loss
of RAP3. RAP3 has homology with RAP2, and the genes are encoded on chromosome 5 in a head-to-tail fashion.
Analysis of the genome databases has identified homologous genes in all Plasmodium spp., suggesting that this
protein plays a role in merozoite invasion. The region surrounding the RAP3 homologue in the Plasmodium
yoelii genome is syntenic with the same region in P. falciparum; however, there is a single gene. Phylogenetic
comparison of the RAP2/3 protein family from Plasmodium spp. suggests that the RAP2/3 duplication occurred
after divergence of these parasite species.
The merozoite form of the asexual life cycle in the blood
stage of Plasmodium spp. attaches to the surface of the eryth-
rocyte, thus initiating the invasion process (23). Ultrastructural
and biochemical studies of merozoites have suggested that the
rhoptries play an essential role in the invasion process. These
electron-dense organelles, part of the apical complex, are con-
nected to the surface of the apical end of the merozoite by a
duct-like structure, and their contents are expelled during
erythrocyte invasion (1). Proteins located on the surface of
merozoites and those released from the apical organelles, the
rhoptries and micronemes, are exposed to the immune system.
Consequently, these proteins are potential vaccine candidates,
and there is considerable interest in the identification and
characterization of proteins in these organelles (2).
A number of proteins located in the rhoptries have been
identified and characterized, such as the low-molecular-mass
rhoptry protein complex of Plasmodium falciparum (28). This
complex consists of various polypeptides, ranging in size from
86 to 37 kDa, that are immunoprecipitated by antibodies to
rhoptry-associated protein 1 (RAP1) (7, 11, 29, 43). Several
studies established that the largest product, reported to be 86
kDa, is a short-lived precursor of the 82-kDa RAP1 protein
and that this 82-kDa protein is further processed to a 67-kDa
protein (7, 26, 27, 29). The 42-kDa protein (also reported as 39
kDa) was found to be the product of a second gene, RAP2 (7,
11, 28, 39, 42). Debate remained regarding the origin of the
40-kDa (or 37-kDa) protein also immunoprecipitated as a part
of the RAP1 complex. It was suggested that this protein was a
breakdown product of either RAP1 or RAP2 (41). It was
subsequently shown, however, that RAP1, RAP2, and RAP3
yield different V8 protease cleavage patterns and are thus
products of three distinct genes (28). The RAP2 and RAP3
proteins, in particular, were hypothesized to be related mole-
cules, possibly precursor and product. The V8 protease diges-
tion patterns for these two proteins were readily distinguish-
able, and additionally it was shown via immunodepletion
experiments that either RAP2 or RAP3, but not both mole-
cules, were bound to a given RAP complex (28).
The precise function of the RAP complex is unknown, but it
is thought to play a role in invasion. Disruption of the RAP1
gene showed that it was not required for merozoite invasion,
although obtaining the gene knockout was difficult, suggesting
some role for the complex in blood stage growth, albeit a
nonessential one (4). Truncation of RAP1 disrupted the inter-
action with RAP2 and RAP3 in the complex. The truncated
form of RAP1 was able to traffic to the rhoptries; however,
RAP2 was apparently retained in the endoplasmic reticulum
(ER). This suggests that a function of RAP1 is to act as an
escorter protein of RAP2 to the rhoptries in P. falciparum (4).
The RAP1 and RAP2 genes have been characterized and
sequenced (41, 42), but the RAP3 gene has yet to be identified.
In this report, we describe the gene encoding RAP3 and show
that this protein is closely related to RAP2. Disruption of the
RAP3 gene showed that the RAP3 protein associated with
RAP1 in the low-molecular-mass complex.
MATERIALS AND METHODS
Sequence analysis. Preliminary sequence data at the Sanger Centre website
(http://www.sanger.ac.uk) were searched for sequence homology to the RAP2
protein by using tblastn. Predicted protein sequences were aligned using Clust-
alX 1.81. The RAP2/RAP3 locus of chromosome 5 was analyzed using the re-
sources at the PlasmoDB web site (http://plasmodb.org) (3).
Parasites and transfection. P. falciparum asexual erythrocytic-stage parasites
were cultivated (47) and synchronized by standard procedures (31). The parasite
line W2mef from Thailand was used in this study (35). W2mef parasites were
transfected, for stable transfection, according to previously published protocols
(22, 49) with 80 g of plasmid that had been purified using the Qiagen (Hilden,
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Germany) plasmid maxi kit. WR99210-resistant transfected parasites were de-
tectable after 2 to 3 weeks of continuous culture. Parasites containing integrated
forms of the plasmid were selected, and cloned lines were obtained by limiting
dilution (15, 50).
The transfection plasmid pHH1RAP3 was constructed by cloning an 810-bp
RAP3 insert with a mutated start codon into the pHH1 transfection vector (38).
This fragment was amplified by using a D10 genomic DNA template and the
forward primer HHR35 (CCCCAGATCTTGTACAGGCGCGCCTAAAAAAC
GATTAGAAAATTTTTGATTTCG [nucleotides 6 to 24]) and the reverse
primer HHR33 (CCCCCTCGAGCCCCCCTAGGGGGATCATCTAAAGAAA
ATGTTTTACTACG [nucleotides 779 to 804 of the coding region]). A BglII
restriction enzyme site (shown in boldface for the forward primer) was intro-
duced at the 5 end of the fragment, and an XhoI restriction enzyme site (shown
in boldface for the reverse primer) was introduced at the 3 end of the fragment
for cloning. The start codon was mutated from ATG to ACG, as indicated by the
underlined base pair in the forward primer. (A schematic representation of the
plasmid is shown in Fig. 3A.)
Nucleic acids and pulsed-field gel electrophoresis. Genomic DNA was ex-
tracted from trophozoite-stage parasites as described previously (12). The anal-
ysis of nucleic acids by Southern blot hybridization and recombinant DNA
techniques were carried out by using standard procedures. Chromosomes were
prepared from trophozoite- and schizont-stage parasites and separated by
pulsed-field gel electrophoresis (9) as described previously (13).
RT-PCR. Total RNA was extracted from synchronized parasite cultures (har-
vested at 10 to 15% parasitemia) by using the RNeasy mini kit (Qiagen) accord-
ing to the manufacturer’s protocol. DNase treatment was performed using the
RNase-free DNase set from Qiagen on the RNeasy mini spin columns as pre-
scribed by the manufacturer. For reverse transcriptase PCR (RT-PCR), 10 l of
total RNA from W2mef parasites was reverse transcribed to cDNA by using an
oligo(dT) primer and the Superscript II First Strand cDNA Synthesis Kit (Gibco
BRL, Gaithersburg, Md.). One microliter of cDNA was then used for each PCR.
The oligonucleotides used for RT-PCR were as follows: forward primer R3
RTPCR, GTATATATTAACACATTTGAG (RAP3 5 untranslated region); re-
verse primer R3int, CACAAAAAGCAAATATATTGG (RAP3 nucleotides 814
to 836 of the coding region); and reverse primer PBDT, CAGTTATAAATAC
AATCAATTGG (pHH1 Plasmodium berghei DT 3 terminator).
Biosynthetic radiolabeling and immunoprecipitation. Trophozoites from syn-
chronized parasite lines were incubated with 300 Ci of [35S]methionine (NEN,
Boston, Mass.) per ml until multinucleated schizonts were apparent, and proteins
were extracted as described previously (27) in 1-ml volumes of 1% T-NET (1%
Triton X-100, 50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 5 mM EDTA) with
Complete (Roche, Mannheim, Germany) protease inhibitor. Immunoprecipita-
tions were performed with the RAP1 monoclonal antibody 7H8/50 (43) and
protein G-Sepharose (Pharmacia Biotech, Uppsala, Sweden). Proteins were sep-
arated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and visual-
ized by enhancement with Amplify (Amersham Pharmacia Biotech, Bucking-
hamshire, United Kingdom) and autoradiography.
Immunofluorescence. Immunofluorescence of synchronized parasitized eryth-
rocytes was performed on air-dried thin smears after fixation at room tempera-
ture in acetone-methanol (9:1) for 5 min. RAP1 was detected using rabbit
antibodies raised to a glutathione S-transferase–RAP1 fusion protein and rho-
damine-labeled goat anti-rabbit antibodies (Chemicon, Temecula, Calif.). RAP2
was detected using mouse monoclonal antibody 7B2/1H1 and fluorescein iso-
thiocyanate-labeled sheep anti-mouse antibodies (Silenus, Melbourne, Austra-
lia). All parasites were also labeled with the 4,6-diamidino-2-phenylindole
(DAPI) DNA stain (Molecular Probes Inc., Eugene, Oreg.).
Enzymatic treatment of erythrocytes and invasion assays. W2mef-infected
erythrocytes are unable to be purified by Percoll gradient centrifugation, and as
a result a novel method was devised to measure erythrocyte invasion (37). This
method is dependent on the inability of W2mef merozoites to invade erythro-
cytes treated with both neuraminidase and trypsin. This method was also adapted
to include the use of [3H]hypoxanthine incorporation to determine the invasion
rate (10). Erythrocytes were treated as reported previously (17) with various
concentrations of either a single enzyme or a combination of enzymes, i.e., 1 mg
of TPCK (L-1-tosylamide-2-phenylethyl chloromethyl ketone)-treated trypsin
(Sigma, St. Louis, Mo.) per ml, 0.5 mg of soybean trypsin inhibitor (Sigma) per
ml, and 0.66 U of Vibrio cholerae neuraminidase (Calbiochem, La Jolla, Calif.)
per ml. Enzyme-treated erythrocytes were then washed twice and adjusted to 4%
hematocrit in hypoxanthine-free culture medium supplemented with 5% serum
and 5% albumax. Parasites were sorbitol synchronized 48 h prior to the invasion
assay. On the day of the assay, ring stage parasites were sorbitol synchronized
once again and then placed back into culture for 2 h. Parasites were adjusted to
2.5% parasitemia in 4% hematocrit. Pellets of parasitized erythrocytes were then
treated with 1 mg of TPCK-treated trypsin per ml and 0.66 U of neuraminidase
per ml for 1 h at 37°C. After washing twice, the parasites were treated with 0.5
mg of soybean trypsin inhibitor per ml. Finally the parasites were washed and
resuspended in hypoxanthine-free culture medium supplemented with 5% hu-
man serum and 5% albumax. The assay was then set up in triplicate, in a final
volume of 100 l, at 0.5% parasitemia in 4% hematocrit in a flat-bottomed
96-well microtiter plate (Becton Dickinson). To allow for reinvasion, parasites
were incubated for 48 h before [3H]hypoxanthine (Amersham Pharmacia Bio-
tech, Buckinghamshire, United Kingdom) was added at a final concentration of
1 Ci per well. After a further 24 h, the cells were frozen and thawed to lyse
infected erythrocytes. Samples were then transferred to glass fiber filters via a cell
harvester (Packard), and [3H]hypoxanthine incorporation was quantitated using
a scintillation counter. The mean number of counts from the triplicate wells was
calculated and expressed as a percentage of the mean counts observed in parallel
cultures of each parasite line in untreated, control erythrocytes.
Nucleotide sequence accession number. The GenBank accession number for
RAP3 is AF516606.
RESULTS
The RAP3 gene is located on chromosome 5 adjacent to
RAP2 in P. falciparum. As RAP2 and RAP3 have similar mo-
lecular masses and they both interact with RAP1 (7, 11, 29, 43),
it was considered likely that they may share some homology.
To test this hypothesis, the RAP2 gene sequence (42) was used
to search the P. falciparum genome sequence database (http://
www.sanger.ac.uk). RAP2 showed homology to a gene pre-
dicted to encode a protein of 44.4 kDa. An alignment of the
putative RAP3 protein with RAP2 shows that these proteins
are homologous, exhibiting 68% similarity and 44% identity
(Fig. 1). The five cysteine residues present in RAP2 are con-
served in the putative RAP3 protein, as is the signal sequence
cleavage site (39, 42). The RAP3 gene from W2mef was cloned
and sequenced and found to be identical to the 3D7 gene
present in the genome database, suggesting that polymor-
phisms in this protein may be limited in the P. falciparum
population.
The RAP2-RAP3 locus of chromosome 5 from P. falciparum
was further analyzed, and a schematic of the genes surrounding
this locus is shown in Fig. 2. RAP2 and RAP3 are in a subte-
lomeric location, closely linked to the P. falciparum inter-
spersed repeat antigen (FIRA) (45, 46) and skeleton binding
protein (Pfsbp1) (6) genes. A gene predicted to encode a nu-
clear scaffold-like protein similar to nuc2 of fission yeast (25)
was also closely linked to RAP2 on the centromeric side of the
locus. The close linkage of the RAP2 and RAP3 genes in a
head-to-tail fashion as well as the high level of similarity sug-
gests that they arose in a gene duplication event.
Search analysis of the murine malaria databases (http://plas-
modb.org) (The Plasmodium Genome Consortium, 2001)
identified a full-length gene in Plasmodium yoelii (PyRAP2/3)
and a partial gene in P. berghei (PbRAP2/3) that have similarity
to RAP2 (PfRAP2) and RAP3 (PfRAP3) from P. falciparum.
Additionally, searching of the Plasmodium vivax (PvRAP2/3)
and Plasmodium knowlesi (PkRAP2/3) sequence databases has
shown that both of these species also have a gene that is
homologous to RAP2 and RAP3. Alignments of the protein
sequences encoded by these genes with the protein sequences
of PfRAP2 and PfRAP3 show that the P. yoelii, P. berghei, P.
knowlesi, and P. vivax proteins have similarity (Fig. 1). The
PyRAP2/3 protein shows 30% identity and 49% similarity to
PfRAP2 and 32% identity and 55% similarity to PfRAP3.
Similarly, PkRAP2/3 has 44% identity and 63% similarity to
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both PfRAP2 and PfRAP3. The signal sequence cleavage site
is conserved in all proteins, as are the positions of three of the
five cysteine residues present in RAP2 and RAP3.
The PyRAP2/3 from P. yoelii was found on a 14.7-kb contig
from the sequence database. The genes surrounding PyRAP2/3
on this contig were predicted to encode homologues to FIRA
(45, 46) and nuc2 (25), the same genes that flank PfRAP2 and
PfRAP3 in P. falciparum (Fig. 2). Therefore P. yoelii has a
single RAP2/3 gene, compared to the duplicated PfRAP2 and
PfRAP3 genes of P. falciparum.
Targeted disruption of the RAP3 gene in P. falciparum. To
disrupt the RAP3 gene, a transfection plasmid was constructed
by cloning an 810-bp fragment from the RAP3 gene into the
vector pHH1 (38) to produce pHH1RAP3 (Fig. 3). The par-
asite line W2mef was transfected with pHH1RAP3 and se-
lected with WR99210. Drug-resistant parasites were selected
FIG. 1. Sequence alignment of PfRAP2, PfRAP3, and the RAP2/3 homologues from P. yoelii, P. berghei, P. knowlesi, and P. vivax. Identical
residues are shown in black, whereas conserved residues are shown in gray. Conserved cysteine residues are indicated by asterisks. The putative
signal cleavage site is indicated by an arrow. PLAFA, P. falciparum; PLAYO, P. yoelii; PLABE, P. berghei; PLAKN, P. knowlesi; PLAVI, P. vivax.
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for those containing integrated forms of the plasmid by one
cycle of cultivation without drug (to permit loss of episomal
plasmid) (Fig. 3). Chromosomes were analyzed from the
W2mef parent and transfected populations W2mefRAP3/0
and W2mefRAP3/1, corresponding to parasites isolated
shortly after transfection or after one round of cycling, respec-
tively (Fig. 3B). As expected, the pGem probe did not recog-
nize the parental W2mef line but hybridized with several bands
in W2mefRAP3/0, corresponding to episomal plasmids that
typically migrate near chromosomes 6 to 8 under these condi-
tions (15, 34). In contrast, W2mefRAP3/1 contained a hy-
bridizing band migrating with chromosome 5, after one cycle
FIG. 2. Organization of the chromosomal region around the RAP2, RAP3, and RAP2/3 genes of P. falciparum and P. yoelii. The nuc2 gene
encodes a nuclear scaffold-like protein of fission yeast. The FIRA gene encodes the P. falciparum interspersed repeat antigen. The sbp1 gene
encodes skeleton binding protein 1.
FIG. 3. Disruption of the RAP3 gene. (A) Integration of the pHH1RAP3 plasmid by single-site homologous recombination produces a
“pseudodiploid,” in which the upstream copy of RAP3 is truncated while the downstream copy lacks a promoter element and has a mutated start
codon. Two copies of the plasmid have been integrated as shown. E, EcoRI; B, BsrGI. (B) Hybridization of a pulsed-field gel electrophoresis blot,
containing separated P. falciparum chromosomes, with pGem plasmid sequences alone (left panel) reveals multiple transgenic sequences in
W2mefRAP3/0, corresponding to episomal plasmid DNA. After cycling of cultures with or without WR99210, stable parasite line
W2mefRAP3/1 exhibits a band that comigrates with chromosome 5 along with a more slowly migrating band that does not correspond to any
chromosome. Two independent clonal isolates derived from the W2mefRAP3/1 transfectants, W2mefRAP3c1 and W2mefRAP3c2, exhibit a
single band that comigrates with chromosome 5. The upper band on both blots corresponds to DNA remaining in the wells. Hybridization of an
identical blot with labeled RAP3 (right) confirms that the pGem sequences are present on the same chromosome as RAP3. (C) Digestion of
genomic DNA with EcoRI or BsrGI confirms that the RAP3 gene has been disrupted in W2mefRAP3c1 and W2mefRAP3c2, yielding the
expected restriction pattern.
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for integration, along with a more slowly migrating band that
did not correspond to a chromosome. This suggested that there
was some integration into the RAP3 gene after one cycle of
selection. Hybridization of an identical filter with RAP3 con-
firmed that the pGem sequences are present on the same
chromosome as RAP3 along with the more slowly migrating
band (Fig. 3B). The latter band is likely to be a concatameric
form of the plasmid, previously observed with other constructs,
that has been shown to consist of several copies of the plasmid
arranged in a head-to-tail orientation in a complex structure
(34). The parasite line W2mefRAP3/1 was cloned by limiting
dilution, and chromosomes from two independent clonal lines
derived from W2mefRAP3/1 were analyzed. These lines, des-
ignated W2mefRAP3c1 and W2mefRAP3c2, showed a sin-
gle hybridizing band migrating with chromosome 5 when hy-
bridized with both plasmid pGem and RAP3 DNA, suggesting
plasmid integration into chromosome 5 (Fig. 3B). These clonal
lines were used for all further experiments.
In order to confirm that the transfected plasmid pHH1RAP3
had integrated by homologous recombination into the RAP3
gene on chromosome 5, purified genomic DNAs from W2mef,
W2mefRAP3c1, and W2mefRAP3c2 were digested with
BsrGI and EcoRI prior to Southern blotting (Fig. 3C). The
RAP3 probe in W2mef detected a single 14.6-kb BsrGI band,
whereas W2mefRAP3c1 and W2mefRAP3c2 showed a
12.9-kb band and two smaller hybridizing bands of 8.3 and 6.6
kb. Similarly, the RAP3 probe detected a 14.8-kb EcoRI frag-
ment in W2mef, whereas in W2mefRAP3c1 and W2mef
RAP3c2, fragments of 11.5, 9.9, and 6.6 kb were obtained. The
extra bands present for EcoRI-digested W2mef are probably
the result of enzyme star activity. Two copies of the plasmid
had integrated, as evidenced by the 6.6-kb BsrGI and EcoRI
fragments, which correspond in size to an extra copy of the
plasmid. These results are consistent with a single-site homol-
ogous recombination between the transfection plasmid and the
endogenous locus, producing a “pseudodiploid” in which the
upstream copy of RAP3 is truncated, while the downstream
copy lacks a promoter element and has a mutated start codon
(Fig. 3A) (14–16, 50).
Several attempts were made to produce antibodies specific
to RAP3. Fusion proteins between RAP3 and glutathione S-
transferase were expressed in Escherichia coli and injected into
rabbits and mice (44), and synthetic RAP3 peptides were also
injected into mice and rabbits. Unfortunately, none of these
numerous attempts was successful. Therefore, in the absence
of specific antisera, RT-PCR was used to analyze the mRNA
transcripts produced by both wild-type and RAP3 parasites to
verify that the RAP3 gene was transcribed and had indeed been
disrupted (Fig. 4). Two sets of primers were used to amplify
cDNA synthesized from total RNA purified from schizont
stages of W2mef, W2mefRAP3c1, and W2mefRAP3c2 par-
asites. One set of primers was specific for a wild-type RAP3
transcript (R3 RTPCR and R3int), while the other primers
were specific for a transcript that would be produced only if the
RAP3 gene was disrupted (R3 RTPCR and PBDT) (Fig. 4A).
A product of approximately 916 bp was obtained using W2mef
cDNA with the R3 RTPCR and R3int oligonucleotides (wild-
type primers) (Fig. 4B, lane 1). A product of the same size was
also obtained by PCR amplification of W2mef genomic DNA
with the wild-type primers (Fig. 4B, lane 5). As a control to
demonstrate that there was no genomic DNA contamination
of the RNA preparation we used primers to the dihydrop-
teroate synthase (DHPS) gene, which has a number of introns
(48). A DNA band of 480 bp was obtained with these primers,
which span an intron, showing no contamination of the RNA
with genomic DNA (Fig. 4B, lane 3). Additionally, controls
that did not include reverse transcriptase failed to show any
bands when they were PCR amplified with wild-type primers
(Fig. 4B, lane 4). As expected, there were no bands amplified
from either wild-type RNA or genomic DNA when mutant-
specific primers (R3 RTPCR and PBDT) were used (Fig. 4B,
lanes 2 and 6). These results demonstrate that the RAP3 gene
is transcribed in wild-type W2mef parasites.
In contrast, there were no products amplified by using wild-
type-specific primers with W2mefRAP3c1 and W2mef
RAP3c2 RNA or genomic DNA, suggesting that the RAP3
gene had been disrupted (Fig. 4C and D, lanes 1 and 5). There
was, however, a product of 1,044 bp amplified by using mutant-
specific primers with both the cDNA and genomic DNA from
RAP3 mutants (Fig. 4C and D, lanes 2 and 6). Once again,
control reactions with primers across an intron of DHPS and
mutant primers with cDNA but no reverse transcriptase veri-
fied that there was no genomic DNA contamination of the
RNA purified from the RAP3 mutant parasites (Fig. 4C and
D, lanes 3 and 4). These results confirm that the RAP3 gene
has been disrupted in the W2mefRAP3c1 and W2m3f
RAP3c2 parasite lines and show that the wild-type mRNA is
not transcribed in these parasites.
Disruption of RAP3 results in loss of the RAP3 protein from
the RAP complex. Due to a lack of specific antisera to RAP3,
it was not possible to directly analyze protein expression in the
RAP3 mutant parasites. Therefore, we used immunoprecipi-
tation of the RAP complex with monoclonal antibodies specific
to RAP1 (Fig. 5). As expected, in W2mef parasites, both RAP2
(42 kDa) and RAP3 (40 kDa) were coprecipitated with RAP1
(82 and 67 kDa) (27, 28, 43). However, in RAP3 mutant
parasites the 42-kDa RAP2 protein coprecipitated with RAP1,
but the 40-kDa RAP3 band was no longer present (Fig. 5).
Therefore, the lack of a 40-kDa band in the RAP complex of
RAP3 mutant parasites demonstrated that the RAP3 gene
encodes the RAP3 component of the low-molecular-mass
rhoptry protein complex.
The RAP3 mutant parasites were analyzed by using immu-
nofluorescence microscopy to determine if loss of RAP3 ex-
pression had an effect on RAP1 and RAP2 subcellular local-
ization. Immunofluorescence microscopy of W2mef schizonts
with either polyclonal rabbit anti-RAP1 or monoclonal anti-
RAP2 antibodies revealed a punctate fluorescence pattern typ-
ical of rhoptry staining (Fig. 6, top row) (11, 27, 29, 41, 43).
Immunofluorescence microscopy of W2mefRAP3c1 para-
sites with the same anti-RAP1 or anti-RAP2 antibodies
showed a fluorescence pattern similar to that for wild-type
parasites (Fig. 6, bottom row). Therefore, the subcellular lo-
calization of RAP1 and RAP2 was unaltered in RAP3 mutant
parasites, indicating that trafficking of these proteins to the
rhoptries is not affected by disruption of the RAP3 gene.
Invasion of erythrocytes by RAP3 mutant parasites. Eryth-
rocyte invasion by P. falciparum is a complex process that is
believed to incorporate redundancies (24, 32, 33). A number of
invasion pathways have been described to date (8, 17, 24).
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These pathways are defined by entry via the erythrocyte sur-
face proteins glycophorin A, glycophorin B, and an unknown
receptor X. It has been shown previously that W2mef parasites
are capable of invading erythrocytes via sialic acid residues
present on both glycophorins A and B (17). To determine if
invasion via these pathways was affected by disruption of
RAP3, the ability of RAP3 mutant parasites to invade human
erythrocytes that had been pretreated with neuraminidase
and/or trypsin was examined. As expected, W2mef parasites
invade these erythrocytes inefficiently (approximately 7.6% of
invasion into normal cells). No significant difference from
W2mef controls in the ability of either the W2mefRAP3c1 or
W2mefRAP3c2 parasites to invade untreated erythrocytes
versus treated erythrocytes was observed (data not shown).
To determine if disruption of RAP3 had an effect on the
growth rate of these parasites, we compared the growth of
wild-type and mutant parasites over a 72-h period. The inva-
sion rates of the W2mef parent and RAP3 mutant parasites in
normal erythrocytes showed no statistically significant differ-
ence. Therefore, disruption of RAP3, and loss of the RAP3
protein from the RAP complex, has not affected the efficiency
of in vitro blood stage growth.
Phylogenetic analysis of the RAP2/3 proteins from plasmo-
dia. A phylogenetic analysis of the six RAP2/3 proteins from
Plasmodium spp. was generated by using the neighbor-joining
algorithm implemented in ClustalX 1.81 of the multiple align-
ment (Fig. 7). The tree shows the divergence between the
primate and murine strains of Plasmodium spp. as determined
by the bootstrap score. Sequence comparison of the C termini
of the proteins in the alignment suggests that the P. knowlesi
and P. vivax proteins have diverged little since speciation of
these two parasites (85% identity and 98% similarity over 69
amino acids). This is in agreement with phylogenetic trees
based on cytochrome b and rRNA sequences (19–21). The
phylogenetic tree shows deep branching of PfRAP2 and
PfRAP3, equal in depth to that of the P. knowlesi protein,
FIG. 4. Transcription of the RAP3 gene is disrupted in W2mefRAP3c1 and W2mefRAP3c2. (A) Schematic of the wild-type RAP3 gene,
showing the locations of the wild-type-specific primers and the expected 916-bp transcript as well as the locations of the mutant-specific primers
and the expected 1,044-bp transcript. Restriction sites shown: E, EcoRI; B, BamHI. (B) PCR products obtained from W2mef wild-type cDNA and
genomic DNA show that the RAP3 gene is transcribed in W2mef parasites. Lanes 1, 4, and 5, wild-type primers; lanes 2 and 6, mutant primers;
lane 3, DHPS control primers. (C) W2mefRAP3c1 cDNA and genomic DNA PCR products indicate that wild-type RAP3 transcripts are not
made in RAP3 mutant parasites. Instead, a mutant transcript is produced, which suggests that a truncated RAP3 protein may be expressed. Lanes
1 and 5, wild-type primers; lanes 2, 4, and 6, mutant primers; lane 3, DHPS control primers. (D) PCR products from W2mefRAP3c2 cDNA and
genomic DNA also show that a mutant transcript but not a wild-type transcript is produced. Lanes 1 and 5, wild-type primers; lanes 2, 4, and 6,
mutant primers; lane 3, DHPS control primers. gDNA, genomic DNA; RT, reverse transcriptase.
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indicating that there has been considerable mutation since the
duplication of these genes and implying that the RAP2-RAP3
gene duplication was an ancient event.
DISCUSSION
Ultrastructural and biochemical studies have suggested that
the rhoptry organelles play an essential role in the invasion
process. The RAP complex, consisting of RAP1, -2, and -3, is
localized to this organelle and may function in merozoite in-
vasion (7, 11, 29, 43). This is supported by the observations that
antibodies to RAP1 inhibit parasite invasion and immunization
with purified RAP complex can protect against P. falciparum
challenge in Saimiri monkeys (36, 40). It is likely that the RAP3
protein together with the other components of this complex
contributed to the protective response observed in those stud-
ies, but without a known gene or protein sequence, further
analysis has not been possible. We have identified the gene
encoding RAP3 and have shown that this protein forms a
complex with RAP1.
The identification of the RAP3 gene in the P. falciparum
genome was based on the strong homology shown with RAP2
and the demonstration that the protein forms a complex with
RAP1. We reasoned that RAP3 would share homology with
RAP2, as they had approximately the same molecular mass
and both interacted with RAP1 separately in the RAP com-
plex. Importantly, disruption of the RAP3 gene resulted in the
loss of the corresponding protein in the RAP complex as
shown by immunoprecipitation with anti-RAP1 antibodies.
This unequivocally demonstrates that the protein encoded by
the RAP3 gene is the 40-kDa RAP3 protein that forms a
complex with RAP1.
Previously, it has been shown that association with RAP1 is
essential for trafficking of RAP2 to the rhoptries during devel-
opment of these organelles (4). Disruption of RAP1-RAP2/3
interactions results in RAP2 being retained in the ER and in
the absence of this complex within the rhoptries. It is likely that
RAP3 was also mislocalized to the ER in parasites expressing
truncated RAP1 (4); however, in the absence of specific anti-
sera to RAP3, it is not possible to prove this unequivocally.
These results have shown that the RAP complex is not essen-
tial for merozoite invasion in the D10 parasite line. Subsequent
attempts to disrupt RAP1 and RAP2 in other P. falciparum
lines have been unsuccessful, suggesting that the proteins en-
coded by these genes provide an important advantage for the
parasite. This is consistent with the conservation of RAP2/3
within Plasmodium spp. and suggests that this complex plays a
role in merozoite invasion of erythrocytes from the broad
range of host organisms that these parasites infect.
It was possible to disrupt RAP3, and it is likely that the
RAP2 protein is able to complement the loss of function of
RAP3. This is consistent with RAP2 and RAP3 forming sep-
arate heterodimers with RAP1 rather than a trimeric complex
FIG. 5. Immunoprecipitation of the RAP complex from W2mef,
W2mefRAP3c1, and W2mefRAP3c2. Purified trophozoites were
metabolically labeled for 6 h with [35S]methionine and immunopre-
cipitated with monoclonal antibody 7H8/50 (left panel); background
binding to protein G beads alone is shown (center panel), and total
labeled protein is also shown (right panel). Both RAP2 (42 kDa) and
RAP3 (40 kDa) were coprecipitated with RAP1 (82 and 67 kDa) in
wild-type W2mef parasites. In the RAP3 mutant parasites the 40-kDa
RAP3 protein no longer coprecipitates with RAP1 and RAP2.
FIG. 6. Subcellular localization of RAP1 and RAP2 in W2mef and W2mefRAP3c1. Antibodies to RAP1 (green) or RAP2 (red) were
incubated with either W2mef or W2mefRAP3c1. The yellow in the merged image indicates colocalization.
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(28). It is interesting that P. falciparum has two homologous
RAP2/3 proteins compared to P. yoelii. This is analogous to
MSP4/5, which is also conserved across Plasmodium spp. Only
one gene has been identified in Plasmodium chabaudi, P. yoelii,
and P. berghei whereas P. falciparum has the two related genes
MSP4 and MSP5 (5, 30). The functional role of two indepen-
dent RAP2/3 proteins in P. falciparum is unknown, but it is
possible that they may play a role in alternate invasion path-
ways for human erythrocytes by P. falciparum. In order to
pursue this possibility, it will be important to determine if the
RAP1, -2, and -3 genes can be disrupted in different parasite
lines by using the new negative-selection transfection vector
that has recently become available (18).
The proteins of the RAP complex are vaccine candidates,
and it is important to develop an understanding of their func-
tion and also their potential role in induction of host protective
immune responses. The identification of the RAP3 gene in this
study will provide the tools to address these questions and to
help understand the functional relationship between RAP1,
RAP2, and RAP3 in P. falciparum.
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